Molecule Details
InChIKeyCZFFBEXEKNGXKS-UHFFFAOYSA-N
Compound NameRaltegravir
Canonical SMILESCc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL7.93
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB06817
Drug NameRaltegravir
CAS Number518048-05-0
Groups approved investigational
ATC Codes J05AR16 J05AJ01
DescriptionRaltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.

Categories: Agents Causing Muscle Toxicity Anti-HIV Agents Anti-Infective Agents Anti-Retroviral Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Antivirals used in combination for the treatment of HIV infections Direct Acting Antivirals Enzyme Inhibitors HIV Integrase Inhibitors Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor Integrase Inhibitors Pyrrolidines Pyrrolidinones UGT1A1 Substrates
Cross-references: BindingDB: 25351 ChEBI: 82960 CHEMBL254316 ChemSpider: 16445111 Drugs Product Database (DPD): 20173 D06676 PDB: RLT PubChem:54671008 PubChem:175427095 RxCUI: 719872 Wikipedia: Raltegravir ZINC: ZINC000013831130
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P32246 CCR1 Homo sapiens Human PF00001 8.3 Ki ChEMBL;BindingDB
P04585 gag-pol Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 7.8 IC50 BindingDB
Q76353 Human immunodeficiency virus type 1 Pathogen PF00552 PF02022 PF00665 7.8 IC50 BindingDB
Q7ZJM1 pol Human immunodeficiency virus type 1 Pathogen PF00552 PF02022 PF00665 7.8 IC50 ChEMBL;BindingDB
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P22309 UGT1A1 UDP-glucuronosyltransferase 1A1 substrate enzymes
Q7ZJM1 pol Gag-Pol polyprotein inhibitor targets
P03366 gag-pol Gag-Pol polyprotein modulator targets